title: Continuation of anakinra despite the development of a pruritic rash in an otherwise refractory case of adult-onset Still's disease.
authors.forename: S
authors.initials: S
authors.lastname: Vordenbäumen
authors.forename: B
authors.initials: B
authors.lastname: Ostendorf
authors.forename: O
authors.initials: O
authors.lastname: Sander
authors.forename: J
authors.initials: J
authors.lastname: Richter
authors.forename: M
authors.initials: M
authors.lastname: Schneider
mesh_terms: D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011537:Pruritus / Q000139:chemically induced*; D012074:Remission Induction; D016706:Still's Disease, Adult-Onset / Q000188:drug therapy*
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein